Search
Ruxotemitide
go.drugbank.com/drugs/DB12748InvestigationalLTX-315 has been used in trials studying the treatment of Cancer, Lymphoma, Melanoma, Carcinoma, and Breast Cancer, among others.
Condoliase
go.drugbank.com/drugs/DB12793InvestigationalCondoliase has been used in trials studying the treatment of Lumbar Disc Disease, Lumbar Vertebra Hernia, and Intervertebral Disc Disease.
Ozanezumab
go.drugbank.com/drugs/DB12891InvestigationalOzanezumab has been used in trials studying the treatment of Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis, Relapsing-Remitting.
Synonyms: IMMUNOGLOBULIN G1, ANTI-(PROTEIN NOGO-A) (HUMAN-MUS MUSCULUS MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL LIGHT CHAIN, DIMERRosemary
go.drugbank.com/drugs/DB14272InvestigationalRosemary is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Iomazenil
go.drugbank.com/drugs/DB14971InvestigationalIomazenil is under investigation in clinical trial NCT01590277 (Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans).
Categories: Heterocyclic Compounds, 2-RingLenrispodun
go.drugbank.com/drugs/DB15039InvestigationalITI-214 is under investigation in clinical trial NCT03489772 (Study of ITI-214 in Healthy Volunteers to Determine CNS Engagement).
Gedivumab
go.drugbank.com/drugs/DB15277InvestigationalGedivumab is under investigation in clinical trial NCT01877785 (A Study of MHAA4549A to Assess Safety And Pharmacokinetics in Healthy Volunteers).
Exicorilant
go.drugbank.com/drugs/DB16162InvestigationalExicorilant is under investigation in clinical trial NCT03437941 (Study to Evaluate CORT125281 in Combination With Enzalutamide in Patients With Mcrpc).
TNP-2092
go.drugbank.com/drugs/DB16312InvestigationalTNP-2092 is under investigation in clinical trial NCT03964493 (TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection).
Categories: Heterocyclic Compounds, 2-Ring, Heterocyclic Compounds with 4 or More RingsPXT 3003
go.drugbank.com/drugs/DB16745InvestigationalPXT 3003 is in phase 3 clinical trials for the treatment of Charcot-Marie-Tooth disease type 1A in adults.